Information Provided By: 
Fly News Breaks for June 27, 2018
ATRC
Jun 27, 2018 | 07:41 EDT
Canaccord analyst Jason Mills raised his price target on AtriCure to $35 from $27 following its analyst day. He said management painted a bullish picture for further adoption and growth of ablation supporting mid-single digit growth. The analyst thinks the company's top-line growth profile could accelerate while gross margins expand, leading to the beginning of free cash flow generation. Mills reiterated his Buy rating on AtriCure shares.
News For ATRC From the Last 2 Days
There are no results for your query ATRC
